PURA and GLUT1: Sweet partners for brain health

• Published in: Biochimica et biophysica acta. Molecular basis of disease 2024-08, Vol.1870 (6), p.167261, Article 167261
• Main Authors: Colombo, Rocío B., Maxit, Clarisa, Martinelli, Diego, Anderson, Mel, Masone, Diego, Mayorga, Lía
• Format: Article
• Language: English
• Subjects: Glucose uptake; GLUT1; PURA; Translational medicine
• ISSN: 0925-4439; 1879-260X; 1879-260X
• DOI: 10.1016/j.bbadis.2024.167261

PURA, also known as Pur-alpha, is an evolutionarily conserved DNA/RNA-binding protein crucial for various cellular processes, including DNA replication, transcriptional regulation, and translational control. Comprising three PUR domains, it engages with nucleic acids and has a role in protein-protein interactions. The manifestation of PURA syndrome, arising from mutations in the PURA gene, presents neurologically with developmental delay, hypotonia, and seizures. In our prior work from 2018, we highlighted the unique case of a PURA patient displaying hypoglycorrhachia, suggesting a potential association with GLUT1 dysfunction in this syndrome. In this current study, we expand the patient cohort with PURA mutations exhibiting hypoglycorrhachia and aim to unravel the molecular basis of this phenomenon. We established an in vitro model in HeLa cells to modulate PURA expression and investigated GLUT1 function and expression. Our findings indicate that PURA levels directly impact glucose uptake through the functioning of GLUT1, without influencing significantly GLUT1 expression. Moreover, our study reveals evidence for a possible physical interaction between PURA and GLUT1, demonstrated by colocalization and co-immunoprecipitation of both proteins. Computational analyses, employing molecular dynamics, further corroborates these findings, demonstrating that PURA:GLUT1 interactions are plausible, and that the stability of the complex is altered when PURA is truncated and/or mutated. In conclusion, our results suggest that PURA plays a pivotal role in driving the function of GLUT1 for glucose uptake, potentially forming a regulatory complex. Additional investigations are warranted to elucidate the precise mechanisms governing this complex and its significance in ensuring proper GLUT1 function. •PURA syndrome is a rare disorder that primarily exhibits neurological symptoms.•Hypoglycorrhachia, a sign of GLUT1 dysfunction, occurs in PURA patients.•Cellular glucose uptake is modulated by PURA through GLUT1.•An apparent interaction between PURA and GLUT1 suggests a complex between them.